SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity

BACKGROUND: Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to be plagued by assay costs and supply chain shortages. In response, we developed SalivaDirect, which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). METHODS: We simplifi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Med (N Y)
Main Authors: Vogels, Chantal B.F., Watkins, Anne E., Harden, Christina A., Brackney, Doug E., Shafer, Jared, Wang, Jianhui, Caraballo, César, Kalinich, Chaney C., Ott, Isabel M., Fauver, Joseph R., Kudo, Eriko, Lu, Peiwen, Venkataraman, Arvind, Tokuyama, Maria, Moore, Adam J., Muenker, M. Catherine, Casanovas-Massana, Arnau, Fournier, John, Bermejo, Santos, Campbell, Melissa, Datta, Rupak, Nelson, Allison, Dela Cruz, Charles S., Ko, Albert I., Iwasaki, Akiko, Krumholz, Harlan M., Matheus, J.D., Hui, Pei, Liu, Chen, Farhadian, Shelli F., Sikka, Robby, Wyllie, Anne L., Grubaugh, Nathan D.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Inc. 2021
Fag:
Clinical and Translational Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836249/
https://ncbi.nlm.nih.gov/pubmed/33521748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medj.2020.12.010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker